Thus, our results suggested that cardiac deletion of the Cdc42 gene significantly alleviated Ang II-induced cardiac hypertrophy by suppressing the activation of the MKK3/6-p38 signaling pathway in the heart. Here, MAP2K3 is linked to cardiac hypertrophy.